Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-12-012197
Filing Date
2012-08-01
Accepted
2012-08-01 18:49:20
Documents
1
Period of Report
2012-08-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 25972
  Complete submission text file 0001179110-12-012197.txt   27394
Mailing Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054 9092701400
WATSON PHARMACEUTICALS INC (Issuer) CIK: 0000884629 (see all company filings)

EIN.: 953872914 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O WATSON PHARMACEUTICALS, INC 311 BONNIE CIRCLE CORONA CA 92880
Business Address
JOYCE R TODD (Reporting) CIK: 0001242066 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13305 | Film No.: 121001327